Elizabeth A Stewart

No ORCID on file · 47 papers in corpus · active 1999-2026

Study types

  • article 30
  • other 7
  • review 5
  • book-chapter 2
  • letter 2

Condition tags

  • adenomyosis 24
  • mesh:D004715 11
  • endometriosis 7
  • infertility 3
  • mesh:D017699 2
  • mesh:D004412 2
  • dysmenorrhea 1
rct
Lancet (London, England) ·doi:10.1016/S0140-6736(22)01475-1

BACKGROUND: Uterine fibroids are common non-cancerous neoplasm that cause heavy menstrual bleeding and other signs. Linzagolix is an oral gonadotropin-releasing hormone receptor antagonist taken once per day that dose-dependently suppresses…

other
Obstetrics and gynecology ·doi:10.1097/AOG.0000000000005145

Uterine leiomyomas are common hormone-responsive neoplasms that frequently cause heavy menstrual bleeding, anemia, pelvic pressure, pain, and adverse reproductive outcomes. In this overview, the efficacy and safety of oral gonadotropin-rele…

other 2026
Menopause (New York, N.Y.) ·doi:10.1097/GME.0000000000002681

OBJECTIVES: To determine the risk of developing de novo carpal tunnel syndrome (CTS), arthritis, or rheumatoid arthritis in women who underwent hysterectomy with bilateral ovarian conservation (H-OC) before reaching spontaneous menopause. …

other 2025
Communications medicine ·doi:10.1038/s43856-025-00961-0

BACKGROUND: The impact of early-life traumatic experiences on late-life morbidity, or chronic conditions, remains unclear. We tested the hypothesis that traumatic adverse childhood experiences, such as physical, verbal, emotional, or sexual…

article 2025
·doi:10.1016/j.fertnstert.2025.07.587
article 2025
·doi:10.1097/aog.0000000000006058
article 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.04.037

OBJECTIVE: To assess the effects of relugolix combination therapy in women with uterine fibroids (UFs) and concomitant ultrasound-diagnosed adenomyosis. DESIGN: This post hoc analysis used pooled data from completers of the pivotal LIBERTY …

article 2024
·doi:10.1093/humrep/deae108.121

Abstract Study question What does the collaborative document on adenomyosis terminology, classification, and diagnosis by ESGE, ESHRE, and WES provides? Summary answer This good practice recommendations paper offers guidance on the technica…

article 2024
F&S science ·doi:10.1016/j.xfss.2024.06.006

Recognizing the limited information, vague diagnostic criterion, and difficult clinical challenges posed by adenomyosis, the Society of Endometriosis and Uterine Disorders organized an expert symposium to present the current understanding o…

article 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1026168

Objective Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of thi…

article 2023
·doi:10.1016/j.fertnstert.2023.08.825
other 2023
Maturitas ·doi:10.1016/j.maturitas.2023.01.012

OBJECTIVE: There is limited information on the prevalence of premature and early menopause. Therefore, we studied the frequency and type of premature (age < 40 years) or early (age 40-44 years) menopause in a geographically-defined American…

article 2023
·doi:10.1089/jwh.2022.0207

Background: Hysterectomy, oophorectomy, and tubal ligation are common surgical procedures. The literature regarding cardiovascular disease (CVD) risk after these surgeries has focused on oophorectomy with limited research on hysterectomy or…

review 2023
Current opinion in obstetrics & gynecology ·doi:10.1097/GCO.0000000000000880

PURPOSE OF REVIEW: Uterine fibroids is a common problem in reproductive-age individuals, frequently causing abnormal uterine bleeding, bulk symptoms, and adverse reproductive outcomes. Traditionally, almost half of the women with symptomati…

article 2023
·doi:10.1097/01.ogx.0000912608.55729.b1

(Abstracted from Eur J Obstet Gynecol Reprod Biol 2020;254:38–43) Adenomyosis is a common, benign uterine disease that causes heavy menstrual bleeding and pelvic pain. A diagnosis of adenomyosis traditionally required hysterectomy, but now …

letter 2022
·doi:10.1097/gme.0000000000002043

Cohen Rassier, Sarah L. MD, MPH; Louie, Michelle Y. MD; Hopkins, Matthew R. MD; Stewart, Elizabeth A. MD; Laughlin-Tommaso, Shannon K. MD Author Information

article 2022
·doi:10.14814/phy2.15445

Women with uterine fibroids (UF), benign tumors of the myometrium, have a higher prevalence of hypertension than women without UF. The cause for this relationship is unclear. Muscle sympathetic nerve activity (MSNA) is a regulator of arteri…

other 2022
Obstetrics and gynecology ·doi:10.1097/AOG.0000000000004916

OBJECTIVE: To evaluate the association of primary infertility with subsequent bilateral oophorectomy and hysterectomy, using a population-based cohort of women with primary infertility and age-matched women in a referent group. METHODS: Th…

article 2021
F&S reports ·doi:10.1016/j.xfre.2021.05.004

OBJECTIVE: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids. DESIGN…

review 2020
Seminars in reproductive medicine ·doi:10.1055/s-0040-1719016

There is no approved medical therapy for adenomyosis and limited evidence to guide treatments in part due to the complexity of nonhistologic diagnosis and the prevalence of concomitant gynecologic conditions. Most available evidence focuses…

review 2020
Seminars in reproductive medicine ·doi:10.1055/s-0040-1721503

Adenomyosis is a poorly understood and clinically underappreciated gynecologic disorder associated with substantial morbidity including dysmenorrhea, pelvic pain, heavy menstrual bleeding, infertility, and poor pregnancy outcomes. Substanti…

article 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.08.040
article 2020
·doi:10.1097/ogx.0000000000000758

(Abstracted from Acta Obstet Gynecol Scand 2019;98:1341–1350) Animal models suggest that increased uterine prolactin concentration is a risk factor for adenomyosis. Prolactin is produced in the human endometrium, myometrium, and the pituita…

book-chapter 2019
·doi:10.1016/b978-0-323-47912-7.00026-3
letter 2019
Fertility and sterility ·doi:10.1016/j.fertnstert.2019.05.036